BTN2A1 acquisition through trogocytosis enhances Vγ9Vδ2 T cell cytotoxicity against autologous and cancer cells

Butyrophilins (BTNs) are emerging as novel druggable immune targets in oncology, promoting the activation of gamma delta (γδ) T cells against cancer cells. Therapies targeting BTN3A or BTN2A1 are under development, but their regulation is poorly understood. Here, we report that lymphocytes' BTN2A1 expression increases with CD3/CD28 stimulation, mediated by trogocytosis in the presence of activated myeloid cells. For instance, BTN2A1 can be acquired by the BTN2A1-knockout (BTN2A1KO) B cell line through trogocytosis when cultured with monocytes. In addition, cytotoxicity assays determine that BTN2A1-acquired normal or tumor cells exhibit higher sensitivity to Vγ9Vδ2 T cell lysis. Finally, we show that trogocytosis-mediated acquisition of BTN2A1 by circulating lymphocytes involves activated monocytes and is correlated with endometrial cancer stage in a cohort of 87 patients. This study provides new insights about the regulation and functions of BTN2A1 but also highlights the potential impact of trogocytosis in regulating the expression of immune checkpoints in normal and pathological conditions.

Authors

Institutions

Publication Details

Journal
Cell Reports
Published
2025-10-01
DOI
https://doi.org/10.1016/j.celrep.2025.116387
Primary Topic
Immune Cell Function and Interaction
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

BTN2A1 acquisition through trogocytosis enhances Vγ9Vδ2 T cell cytotoxicity against autologous and cancer cells

Marie-Sarah Rouviére, Caroline Imbert, Renaud Sabatier, Nicolas Boucherit et al.
Cell Reports
Immune Cell Function and Interaction
article

BTN2A1 acquisition through trogocytosis enhances Vγ9Vδ2 T cell cytotoxicity against autologous and cancer cells

Marie-Sarah Rouviére, Caroline Imbert, Renaud Sabatier, Nicolas Boucherit, Amira Ben Amara, Paolo Grassi, Daniel Olive, Philippe Livrati, Laurent Gorvel, Emilien Billon, Jacques A. Nunès, Éric Lambaudie, Gwénaëlle Gravis, Lucie Robert, Manon Richaud, Anne-Sophie Chrétien, Damien Bruyat, Téo Fernez
article en

Abstract

Butyrophilins (BTNs) are emerging as novel druggable immune targets in oncology, promoting the activation of gamma delta (γδ) T cells against cancer cells. Therapies targeting BTN3A or BTN2A1 are under development, but their regulation is poorly understood. Here, we report that lymphocytes' BTN2A1 expression increases with CD3/CD28 stimulation, mediated by trogocytosis in the presence of activated myeloid cells. For instance, BTN2A1 can be acquired by the BTN2A1-knockout (BTN2A1KO) B cell line through trogocytosis when cultured with monocytes. In addition, cytotoxicity assays determine that BTN2A1-acquired normal or tumor cells exhibit higher sensitivity to Vγ9Vδ2 T cell lysis. Finally, we show that trogocytosis-mediated acquisition of BTN2A1 by circulating lymphocytes involves activated monocytes and is correlated with endometrial cancer stage in a cohort of 87 patients. This study provides new insights about the regulation and functions of BTN2A1 but also highlights the potential impact of trogocytosis in regulating the expression of immune checkpoints in normal and pathological conditions.

Cell ReportsVol. 44(10)
Centre National de la Recherche Scientifique (FR), Inserm (FR), Centre de Recherche en Cancérologie de Marseille (FR), Institut Paoli-Calmettes (FR)
Openalex Percentile: Top 71%
Immune Cell Function and Interaction
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.